Recordati Rare Diseases North America
Laszlo Hidvegi Pharm.D. has extensive experience in the pharmaceutical and biotechnology sectors, currently serving as the National Project Manager at Recordati Rare Diseases Inc. since April 2020. Previously, Laszlo held various senior roles at CSL Behring, including Franchise Manager for perioperative bleeding and hospital products, and Marketing Manager across multiple medical specialties. Prior positions at Merck Kft. involved responsibilities such as Business Unit Manager for CH/OTC, Fertility & Endocrinology, and Senior Product Manager for Diabetes. Additional experience includes roles at Roche Kft. and Abbott, focusing on product management and business development in psychiatry, infectology, and urology. Laszlo holds a degree from Semmelweis Medical University Faculty of Pharmacology and completed secondary education at Móricz Zsigmond Secondary School.
This person is not in any offices
Recordati Rare Diseases North America
1 followers
Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.